Patent ID: 8680098

Claim:
A compound of formula (I) wherein R 1 is selected from the group consisting of hydrogen, fluoro, chloro, fluorinated C 1-4 -alkyl and fluorinated C 1-4 -alkoxy; R 2 is selected from the group consisting of hydrogen, chloro, bromo, C 1-4 -alkyl, fluorinated C 1-4 -alkyl and fluorinated C 1-4 -alkoxy; provided that when R 2 is other than hydrogen, wherein R 3 is selected from the group consisting of hydrogen, chloro, cyano, C 1-4 -alkyl, fluorinated C 1-4 alkyl, C 1-4 -alkoxy, fluorinated C 1-4 alkoxy, —O—(CH 2 ) 2 —OH, —O—CH 2 —CO 2 H, —O—(CH 2 ) 2 —O—(C 1-4 alkyl), —O—CH 2 -(fluorinated C 1-2 alkyl), —O—(CH 2 ) 2 —NR A R B and —NR A R B ; wherein R A and R B are each independently selected from the group consisting of hydrogen and C 1-4 -alkyl; alternatively R A and R B are taken together with the nitrogen atom to which they are bound to form a ring structure selected form the group consisting of pyrrolidin-1-yl, piperidin-1-yl, piperazin-1-yl, 4-methyl-piperidin-1-yl, 4-methyl-piperazin-1-yl and morpholin-4-yl; Q is an optionally substituted ring structure selected from the group consisting of formulas (a) through (h) wherein R 5 is C 1-4 -alkyl; R 6 is selected from the group consisting of C 1-4 -alkyl and fluorinated C 1-4 -alkyl; and R 7 is selected from the group consisting of hydrogen, chloro, fluoro, cyano, C 1-4 alkyl and C 1-4 alkoxy; wherein R 8 and R 9 are each independently selected from the group consisting of C 1-4 alkyl; wherein R 10 is C 1-4 -alkyl; and R 11 is selected from the group consisting of hydrogen and cyano; wherein R 12 and R 13 are each independently selected from the group consisting of hydrogen and C 1-4 -alkyl; wherein R 14 is C 1-4 alkyl; wherein R 15 is C 1-4 -alkyl; and R 16 is selected from the group consisting of hydrogen, chloro and bromo; and wherein R 17 is C 1-4 -alkyl; or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof.